You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

SULFISOXAZOLE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sulfisoxazole patents expire, and what generic alternatives are available?

Sulfisoxazole is a drug marketed by Ani Pharms, Barr, Heather, Impax Labs, Lannett, Lederle, Pharmeral, Purepac Pharm, Rising, Roxane, Valeant Pharm Intl, Vitarine, Watson Labs, West Ward, and Sola Barnes Hind. and is included in fifteen NDAs.

The generic ingredient in SULFISOXAZOLE is sulfisoxazole diolamine. There are three drug master file entries for this compound. Additional details are available on the sulfisoxazole diolamine profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SULFISOXAZOLE?
  • What are the global sales for SULFISOXAZOLE?
  • What is Average Wholesale Price for SULFISOXAZOLE?
Summary for SULFISOXAZOLE
Drug patent expirations by year for SULFISOXAZOLE
Recent Clinical Trials for SULFISOXAZOLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4
University of LouisvilleEarly Phase 1

See all SULFISOXAZOLE clinical trials

Medical Subject Heading (MeSH) Categories for SULFISOXAZOLE

US Patents and Regulatory Information for SULFISOXAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms SULFISOXAZOLE sulfisoxazole TABLET;ORAL 080142-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmeral SULFISOXAZOLE sulfisoxazole TABLET;ORAL 084385-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs SULFISOXAZOLE sulfisoxazole TABLET;ORAL 080109-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Vitarine SULFISOXAZOLE sulfisoxazole TABLET;ORAL 087332-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.